|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 367.99 USD | -0.03% |
|
361.56 | -1.75% |
| Jul. 08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| Jul. 08 | Morgan Stanley Adjusts Price Target Amgen to $333 From $340, Maintains Equalweight Rating | MT |
| Market Cap | 199B 174B 161B 149B 282B 19,017B 287B 1,933B 751B 9,306B 746B 729B 32,306B | P/E 2026 * |
24.1x | P/E 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 241B 211B 195B 180B 341B 23,045B 348B 2,343B 910B 11,277B 904B 884B 39,149B | EV / Sales 2026 * |
6.37x | EV / Sales 2027 * | 6.08x |
| Free-Float |
99.78% | Yield 2026 * |
2.74% | Yield 2027 * | 2.9% |
Last Transcript: Amgen Inc.
| 1 day | -0.03% | ||
| 1 week | +1.84% | ||
| Current month | +1.62% | ||
| 1 month | +6.44% | ||
| 3 months | +5.20% | ||
| 6 months | +11.47% | ||
| Current year | +12.43% |
| 1 week | 359.47 |  | 375.25 |
| 1 month | 334.05 | | 375.25 |
| Current year | 318.21 | | 391.29 |
| 1 year | 269.77 | | 391.29 |
| 3 years | 218.61 | | 391.29 |
| 5 years | 198.64 | | 391.29 |
| 10 years | 133.64 | | 391.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.03% | +1.84% | +23.90% | +68.30% | 199B | |
| -1.60% | +2.02% | +56.34% | +168.94% | 1,084B | |
| -1.44% | +3.71% | +69.07% | +65.40% | 634B | |
| -0.75% | +0.67% | +33.18% | +86.52% | 447B | |
| -1.35% | +1.86% | +29.96% | +26.28% | 330B | |
| -0.86% | +2.79% | +37.72% | +40.85% | 295B | |
| -0.71% | +0.72% | +28.85% | +48.27% | 285B | |
| -1.31% | -0.26% | -28.18% | -39.82% | 218B | |
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | |
| -0.08% | +0.71% | -6.13% | -32.31% | 137B | |
| Average | -0.85% | +2.34% | +26.70% | +51.49% | 379.69B | |
| Weighted average by Cap. | -1.12% | +2.42% | +39.62% | +82.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.77B 33.13B 30.59B 28.27B 53.58B 3,617B 54.65B 368B 143B 1,770B 142B 139B 6,144B | 38.7B 33.95B 31.34B 28.96B 54.89B 3,706B 55.99B 377B 146B 1,814B 145B 142B 6,295B |
| Net income | 8.23B 7.22B 6.67B 6.16B 11.67B 788B 11.91B 80.13B 31.13B 386B 30.91B 30.23B 1,339B | 8.86B 7.78B 7.18B 6.63B 12.57B 849B 12.82B 86.3B 33.53B 415B 33.29B 32.56B 1,442B |
| Net Debt | 42.07B 36.9B 34.07B 31.48B 59.67B 4,028B 60.86B 410B 159B 1,971B 158B 155B 6,843B | 36.52B 32.03B 29.57B 27.32B 51.79B 3,496B 52.83B 355B 138B 1,711B 137B 134B 5,940B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | $367.99 | -0.03% | 1,758,925 |
| 26-07-07 | $368.10 | +0.45% | 1,983,666 |
| 26-07-06 | $366.44 | -2.06% | 2,838,007 |
| 26-07-02 | $374.15 | +3.55% | 2,487,837 |
| 26-07-01 | $361.33 | -0.22% | 2,244,791 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
